AseBio and Alira Health Partner to Foster Market Access for Biotech Startups

News
Published on:
September 27, 2022

Alira Health, a global healthcare advisory and technology company, and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.

Together, AseBio and Alira Health will provide a market access mentoring program for AseBio members to promote access to innovation.

Alira Health, a member of AseBio since Spring 2022, will pair its experienced market access consultants with companies to improve their value proposition, navigate the ecosystem, and properly define their market access needs. The program features a 40-hour service package that includes an initial meeting, background analysis, tailored orientation session for market access and pricing, and gap analysis.

It is a pleasure for us as Alira Health to collaborate with AseBio in this mentoring program. We hope that this will allow us to help biotech companies have better access to the market, and in addition, train companies in areas where they need development.”
Chus Castillo Vice President, Market Access, Alira Health (Iberia)

The program will start in November 2023, and application is open to all AseBio SMEs. Three companies will be selected for the inaugural program.

Ion Arocena, General Director at AseBio, and Chus Castillo, Vice President of Market Access at Alira Health (Iberia), attended the signing event.

“It is a pleasure for us as Alira Health to collaborate with AseBio in this mentoring program. We hope that this will allow us to help biotech companies have better access to the market, and in addition, train companies in areas where they need development”, says Chus Castillo, Vice President of Market Access at Alira Health (Iberia).

Would you like to learn more about Alira Health’s partnership with AseBio? Watch this interview with our team.

Related news

Publications September 15, 2023
Leveraging a Virtual Site to Boost Diversity and Enrollment
The client’s study aimed to assess the sensitivity and specificity of a novel diagnostic test for colorectal cancer in a large population representative of the diversity in the US.(...)
Biotech
News September 8, 2023
Alira Health Partners With Col·legi de Metges de Barcelona
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Market Access Spain Startups
Blog September 6, 2023
Execution: How Biotechs Can Plan and Run Successful Clinical Trials
Biotech experts Joris Pezzini and Chris Rao answer questions about the challenges of executing a successful clinical trial.
Biotech
Events August 16, 2023
BioSpain
We are excited to attend, speak at, and sponsor BioSpain, one of the leading conferences in the European biotechnology field.
Biotech Spain
Events August 10, 2023
12th EPP Life Sciences Pricing Forum
We are excited to speak at the 12th EPP Life Sciences Pricing Forum for pricing directors and executives in Life Sciences.
EU Market Access
Events July 31, 2023
LSI Europe Emerging MedTech Summit
We will attend LSI Europe Emerging MedTech Summit in Barcelona to discuss the latest advancements, challenges, and trends in the industry.
MedTech Spain
Events July 31, 2023
World Vaccine Congress
We are pleased to announce that we will attend The World Vaccine Congress Europe, the largest and most established European meeting on vaccine R&D.
Drug Development Spain Vaccines
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.